BZ6-10413-90928
3 vaccinations
10 coded responses
29 check-ins
10 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 730 / OK
- Registered
- 2021-03-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-16
Registered in v-safe
-
2021-03-16
Dose 1 — Pfizer-BioNTech
-
2021-03-16
Survey response — day 0, dose 1MedDRA: No adverse event — Feeling: Fair · Site: Swelling · Joint pains, Muscle or body achesFree text: NoneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-17
-
2021-03-18
Survey response — days 1–6 daily, dose 1MedDRA: Chest discomfort — Feeling: GoodFree text: Tightness in chestMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-20
Survey response — days 1–6 daily, dose 1MedDRA: Chest discomfort, Cough — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Tight chest; some coughingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-21
Survey response — days 1–6 daily, dose 1MedDRA: Chest discomfort — Feeling: Good · Site: SwellingFree text: Chest still tight but not as much as yesterdayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-22
Survey response — days 1–6 daily, dose 1MedDRA: Chest discomfort — Feeling: GoodFree text: Continued tightness in chestMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-23
Survey response — day 7, dose 1MedDRA: Chest discomfort — Feeling: Poor · Fever · Chills, Headache, Nausea, Vomiting · Be unable to do your normal daily activitiesFree text: Still tightness in chestMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-30
-
2021-04-06
Dose 2 — Pfizer-BioNTech
-
2021-04-06
Health check-in — day 0, dose 2Feeling: Fair · Chills, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling · Chills, Fatigue or tirednessAdult check-in
-
2021-04-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-10
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain — Feeling: Fair · Joint pains, Fatigue or tirednessFree text: Some pain raising right arm (injection site)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-11
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Chills, Fatigue or tirednessAdult check-in
- 2021-04-13
- 2021-04-20
- 2021-04-27
- 2021-05-04
-
2021-05-11
Survey response — day 35, dose 2MedDRA: Chest pain, Cough, Dizziness, Gastrooesophageal reflux disease, Pyrexia — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Phlegmy cough, mid-chest hurts when I cough, dizziness, acid backup, slight tempMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-11
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-18
-
2021-07-06
Survey response — 3 months, dose 2MedDRA: Fatigue, Pain, Pre-existing disease, Rheumatoid arthritis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I began having a series of RA flares, resulting in an increase of medication to stop the pain which was followed by extreme fatigue.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-06
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-08
Call successfulDoes not wish to fill out VAERS report
-
2021-07-08
Call successfulDoes not wish to fill out VAERS report
-
2021-09-08
Dose 3 — Pfizer-BioNTech
- 2021-10-05
- 2021-10-06
- 2021-10-13
- 2021-10-20
- 2021-12-08
-
2022-03-09
Survey response — 6 months, dose 3MedDRA: Thyroid mass, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Possible precancerous cells/nodules found in thyroid gland.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-09
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-10
- 2022-09-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Pfizer-BioNTech | |
| 2 | 2021-04-06 | Pfizer-BioNTech | |
| 3 | 2021-09-08 | Pfizer-BioNTech | No |
Call center
3 call center cases
2 successful · 1 unsuccessful
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): None
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Tightness in chest
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Tight chest; some coughing
Systemic reaction (other): Chest still tight but not as much as yesterday
Systemic reaction (other): Continued tightness in chest
Release 6 — day 7, dose 1
Systemic reaction (other): Still tightness in chest
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Some pain raising right arm (injection site)
Release 8 — day 35, dose 2
Symptoms: Phlegmy cough, mid-chest hurts when I cough, dizziness, acid backup, slight temp
Release 9 — 3 months, dose 2
Symptoms: I began having a series of RA flares, resulting in an increase of medication to stop the pain which was followed by extreme fatigue.
Release 11 — 6 months, dose 3
Symptoms: Possible precancerous cells/nodules found in thyroid gland.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest pain | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Gastrooesophageal reflux disease | ✓ | ✓ | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Rheumatoid arthritis | · | · | ✓ |
| SD | Thyroid mass | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Chest discomfort | ✓ | ✓ | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release